Editorial
doi: 10.1001/archderm.142.5.633.
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks
- PMID: 16702502
- DOI: 10.1001/archderm.142.5.633
Item in Clipboard
Editorial
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks
Arch Dermatol.
2006 May.
No abstract available
Comment in
-
Topical calcineurin inhibitors labeling: putting the "box" in perspective.Arch Dermatol. 2006 Sep;142(9):1233-5. doi: 10.1001/archderm.142.9.1233. Arch Dermatol. 2006. PMID: 16983018 No abstract available.
Comment on
-
Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.Arch Dermatol. 2006 May;142(5):555-8. doi: 10.1001/archderm.142.5.555. Arch Dermatol. 2006. PMID: 16702492 No abstract available.
-
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children.Arch Dermatol. 2006 May;142(5):561-6. doi: 10.1001/archderm.142.5.561. Arch Dermatol. 2006. PMID: 16702493
Similar articles
-
[Topical calcineurin inhibitors in atopic eczema -- pro].Dtsch Med Wochenschr. 2006 Jul 14;131(28-29):1614. doi: 10.1055/s-2006-947807. Dtsch Med Wochenschr. 2006. PMID: 16823713 German. No abstract available.
-
Topical calcineurin inhibitors labeling: putting the "box" in perspective.Arch Dermatol. 2006 Sep;142(9):1233-5. doi: 10.1001/archderm.142.9.1233. Arch Dermatol. 2006. PMID: 16983018 No abstract available.
-
Topical calcineurin inhibitors revisited.Arch Dermatol. 2007 Apr;143(4):545-6. doi: 10.1001/archderm.143.4.545. Arch Dermatol. 2007. PMID: 17438195 No abstract available.
-
The role of topical calcineurin inhibitors in atopic dermatitis.Br J Dermatol. 2004 Dec;151 Suppl 70 Dec 2004:3-27. doi: 10.1111/j.1365-2133.2004.06269.x. Br J Dermatol. 2004. PMID: 15548171 Review.
-
Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Pharmacotherapy. 2007 Jul;27(7):1020-8. doi: 10.1592/phco.27.7.1020. Pharmacotherapy. 2007. PMID: 17594208 Review.
Cited by
-
Pathways to managing atopic dermatitis: consensus from the experts.J Clin Aesthet Dermatol. 2013 Jul;6(7 Suppl):S2-S18. J Clin Aesthet Dermatol. 2013. PMID: 24171071 Free PMC article. No abstract available.
-
Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, as Therapeutic Option in Vitiligo.Methods Mol Biol. 2024;2849:185-202. doi: 10.1007/7651_2023_510. Methods Mol Biol. 2024. PMID: 38189899
-
The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.Drug Saf. 2008;31(3):185-98. doi: 10.2165/00002018-200831030-00001. Drug Saf. 2008. PMID: 18302444 Review.
-
Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis.Expert Rev Clin Pharmacol. 2023 Feb;16(2):119-131. doi: 10.1080/17512433.2023.2173172. Epub 2023 Feb 6. Expert Rev Clin Pharmacol. 2023. PMID: 36705936 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
